Controlling Aggregates In mAb Downstream Process Development
Source: Cytiva
Aggregate formation reduces quality and yield in downstream processing of mAbs and antibody variants. But there are ways to manage it.
In this on-demand webinar we share practical strategies to prevent and reduce aggregation across key downstream unit operations including chromatography and tangential flow filtration (TFF).
Content:
- Capture strategies to prevent aggregation
- Polishing strategies to remove aggregates
- Optimizing concentration and diafiltration to mitigate aggregation in high-concentration mAbs
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader